Incidence of endocrine-related immune-related adverse events in Japanese subjects with various types of cancer

Incidence of endocrine-related immune-related adverse events in Japanese subjects with various types of cancer

BackgroundImmune checkpoint inhibitors (ICIs), such as cytotoxic T lymphocyte antigen-4 (CTLA-4) inhibitors, programmed cell death protein 1 (PD-1) inhibitors, and programmed cell death protein 1 ligand 1 (PD-L1) inhibitors, are often used to treat a variety of malignancies. ICIs are known to cause...

Full description

Bibliographic Details
Main Authors: Yuichiro Iwamoto, Tomohiko Kimura, Hideyuki Iwamoto, Junpei Sanada, Yoshiro Fushimi, Yukino Katakura, Fuminori Tatsumi, Masashi Shimoda, Shuhei Nakanishi, Tomoatsu Mune, Kohei Kaku, Hideaki Kaneto
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-01-01
Series:Frontiers in Endocrinology
Subjects:
immune-related adverse events
immune check point inhibitors
cytotoxic T lymphocyte antigen-4 inhibitors
programmed cell death protein 1 inhibitor
programmed cell death protein 1 ligand 1 inhibitors
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2023.1079074/full

Internet

https://www.frontiersin.org/articles/10.3389/fendo.2023.1079074/full

Similar Items